Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Int J Mol Sci. 2023 Oct 11;24(20):15071. doi: 10.3390/ijms242015071.
ABSTRACT
The multifactorial etiology of major depressive disorder (MDD) includes biological, environmental, genetic, and psychological aspects. Recently, there has been an increasing interest in metallomic studies in psychiatry, aiming to evaluate the role of chosen trace elements in the MDD etiology as well as the progression of symptoms. This narrative review aims to summarize the available literature on the relationship between the concentration of chosen elements in the serum of patients with MDD and the onset and progression of this psychiatric condition. The authors reviewed PubMed, Web of Science, and Scopus databases searching for elements that had been investigated so far and further evaluated them in this paper. Ultimately, 15 elements were evaluated, namely, zinc, magnesium, selenium, iron, copper, aluminium, cadmium, lead, mercury, arsenic, calcium, manganese, chromium, nickel, and phosphorus. The association between metallomic studies and psychiatry has been developing dynamically recently. According to the results of current research, metallomics might act as a potential screening tool for patients with MDD while at the same time providing an assessment of the severity of symptoms. Either deficiencies or excessive amounts of chosen elements might be associated with the progression of depressive symptoms or even the onset of the disease among people predisposed to MDD.
PMID:37894749 | DOI:10.3390/ijms242015071
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Trace Elements Levels in Major Depressive Disorder-Evaluation of Potential Threats and Possible Therapeutic Approaches
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Shining a Light on Trace Elements: A Systematic Review and Meta-analysis of Serum Concentrations in Febrile seizure Shining a Light on Trace Elements: A Systematic Review and Meta-analysis of Serum Concentrations in Febrile seizure Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease A genome-wide association study provides insights into the genetic etiology of 57 essential and non-essential trace elements in humans Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder Are Advanced Oxidation Protein Products (AOPPs) Levels Altered in Neuropsychiatric Disorders? An Integrative Review The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder The metabolome-wide signature of major depressive disorder Treating depression in patients with borderline personality disorder: clinical clues on the use of antidepressants Gender differences in plasma S100B levels of patients with major depressive disorder Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder Personalized, Precision Medicine to Cure Alzheimer's Dementia: Approach #1 Mediation of social anxiety and depression during internet-delivered treatment for social anxiety disorder Cortical activation for adolescent-onset minor depression and major depressive disorder: an fNIRS study Cortical activation for adolescent-onset minor depression and major depressive disorder: an fNIRS study Interaction between HTR2A rs3125 and negative life events in suicide attempts among patients with major depressive disorder: a cross-sectional study Exploring the Effects of Major Depressive Disorder on Daily Occupations and the Impact of Psychotherapy: A Literature Review Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders Defining "High Recurrence" of Depressive Episodes for Predicting Diagnostic Conversion from Major Depressive Disorder to Bipolar Disorder: A 5-year Retrospective Study Elevated thyroid stimulating hormone and metabolic syndrome risk in patients with first-episode and drug-naïve major depressive disorder: a large-scale cross-sectional study Association of clinical variables and thyroid-stimulating hormone with psychotic symptoms in patients with first-episode and drug-naïve major depressive disorder with elevated fasting blood glucose: preliminary exploratory study with a large sample AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain Global prevalence of major depressive disorder in LGBTQ+ samples: A systematic review and meta-analysis of epidemiological studies The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records Molecular mechanisms underlying structural plasticity of electroconvulsive therapy in major depressive disorder Association of major depression, schizophrenia and bipolar disorder with thyroid cancer: a bidirectional two-sample mendelian randomized study Diagnostic conversion to bipolar disorder among adolescents and young adults with major depressive disorder: a nationwide longitudinal study Inflammatory mediators in major depression and bipolar disorder An association study of m6A methylation with major depressive disorder Gender Differences in the Prevalence and Clinical Correlates of Metabolic Syndrome in First-Episode and Drug-Naïve Patients With Major Depressive Disorder Inflammation and immune system pathways as biological signatures of adolescent depression-the IDEA-RiSCo study Altered intersubject functional variability of brain white-matter in major depressive disorder and its association with gene expression profiles Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression Affective disorders and the loudness dependence of the auditory evoked potential: Serotonin and beyond Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) Prevalence and clinical correlates of suicide attempts in patients with first-episode drug-naïve major depressive disorder and comorbid autoimmune thyroiditis Adolescent and Adult Transitions From Major Depressive Disorder to Bipolar Disorder Relationship of Major Depressive Disorder and Schizophrenia Polygenic Risk Scores to Suicide: A Comparison Between European and Asian Ancestry Populations Relationship of Major Depressive Disorder and Schizophrenia Polygenic Risk Scores to Suicide: A Comparison Between European and Asian Ancestry Populations Innova4Health: an integrated approach for prevention of recurrence and personalized treatment of Major Depressive Disorder Innova4Health: an integrated approach for prevention of recurrence and personalized treatment of Major Depressive Disorder Shared genetic effect of kidney function on bipolar and major depressive disorders: a large-scale genome-wide cross-trait analysis Cannabis use and mood disorders: a systematic review Comparing Symptoms of Major Depression in Youth with Confirmed Versus Suspected Bipolar Disorder Altered effective connectivity among face-processing systems in major depressive disorder Human olfactory neural progenitor cells reveal differences in IL-6, IL-8, thrombospondin-1, and MCP-1 in major depression disorder and borderline personality disorder High-definition transcranial direct current stimulation (HD-tDCS) in major depressive disorder with anxious distress-a study protocol for a double-blinded randomized sham-controlled trial The Association of Redox Regulatory Drug Target Genes with Psychiatric Disorders: A Mendelian Randomization Study Social determinants of mental health in major depressive disorder: Umbrella review of 26 meta-analyses and systematic reviews Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report Differences in fractional amplitude of low-frequency fluctuations (fALFF) and cognitive function between untreated major depressive disorder and schizophrenia with depressive mood patients Epigenetic alterations in patients with anorexia nervosa-a systematic review
Evidence Blueprint
Trace Elements Levels in Major Depressive Disorder-Evaluation of Potential Threats and Possible Therapeutic Approaches
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Trace Elements Levels in Major Depressive Disorder-Evaluation of Potential Threats and Possible Therapeutic Approaches
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Shining a Light on Trace Elements: A Systematic Review and Meta-analysis of Serum Concentrations in Febrile seizure Shining a Light on Trace Elements: A Systematic Review and Meta-analysis of Serum Concentrations in Febrile seizure Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease A genome-wide association study provides insights into the genetic etiology of 57 essential and non-essential trace elements in humans The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review Effects of sex and gender on the etiologies and presentation of select internalizing psychopathologies Prevalence and factors associated with metabolic syndrome in first hospitalization for major depression disorder patients Serum levels of interleukin-33 and mesencephalic astrocyte derived neurotrophic factors in patients with major depressive disorder: a cross-sectional comparative design Major depressive disorder (mdd): emerging immune targets at preclinical level Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential Deep brain stimulation for refractory major depressive disorder: a comprehensive review Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder Mitochondrial and Cellular Function in Fibroblasts, Induced Neurons, and Astrocytes Derived from Case Study Patients: Insights into Major Depression as a Mitochondria-Associated Disease Cytokine profile in first-episode drug-naïve major depressive disorder patients with or without anxiety Is adjustment disorder genetically correlated with depression, anxiety, or risk-tolerant personality trait? Proinflammatory cytokine levels, cognitive function, and suicidal symptoms of adolescents and young adults with major depressive disorder Are Advanced Oxidation Protein Products (AOPPs) Levels Altered in Neuropsychiatric Disorders? An Integrative Review Biological markers of sex-based differences in major depressive disorder and in antidepressant response The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder Resilience and Attachment in Patients with Major Depressive Disorder and Bipolar Disorder Elevated Plasma Levels of Mature Brain-Derived Neurotrophic Factor in Major Depressive Disorder Patients with Higher Suicidal Ideation Individual and Combined Effect of MAO-A/MAO-B Gene Variants and Adverse Childhood Experiences on the Severity of Major Depressive Disorder Cerebral cortical structural alteration patterns across four major psychiatric disorders in 5549 individuals Shared genetics and causal relationships between major depressive disorder and COVID-19 related traits: a large-scale genome-wide cross-trait meta-analysis Major Depressive Disorder, Inflammation, and Nutrition: A Tricky Pattern? Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis A Review of the Nutritional Approach and the Role of Dietary Components in Children with Autism Spectrum Disorders in Light of the Latest Scientific Research Effect modification of tumor necrosis factor-α on the kynurenine and serotonin pathways in major depressive disorder on type 2 diabetes mellitus Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder Mendelian randomization studies of depression: evidence, opportunities, and challenges Relationship between biological rhythm dysregulation and suicidal ideation in patients with major depressive disorder The Association of HHV-6 and the TNF-α (-308G/A) Promotor with Major Depressive Disorder Patients and Healthy Controls in Thailand The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder Prevalence and clinical correlates of psychotic symptoms in first-episode untreated female chinese patients with major depressive disorder Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper Deciphering the neural mechanisms of miR-134 in major depressive disorder with population-based and person-specific imaging transcriptomic techniques A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder Upregulation of HDAC9 in hippocampal neurons mediates depression-like behaviours by inhibiting ANXA2 degradation The metabolome-wide signature of major depressive disorder Role of trazodone in treatment of major depressive disorder: an update Comparison of childhood trauma between depressive disorders and personality disorders Treating depression in patients with borderline personality disorder: clinical clues on the use of antidepressants Validation of the maximal cardiopulmonary exercise test in adolescents with major depressive disorder and comparison of cardiorespiratory fitness with sex- and age-related control values Lack of association between VNTR variant of the circadian gene (PER3) and major depressive disorder in a sample of a Turkish population Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression Key subphenotypes of bipolar disorder are differentially associated with polygenic liabilities for bipolar disorder, schizophrenia, and major depressive disorder The effectiveness of mindfulness yoga on patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials Gender differences in plasma S100B levels of patients with major depressive disorder Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder Influences of Genetic and Environmental Factors on Chronic Migraine: A Narrative Review Exploring the clinical characteristics and etiological factors of comorbid major depressive disorder and social anxiety disorder Personalized, Precision Medicine to Cure Alzheimer's Dementia: Approach #1 Mediation of social anxiety and depression during internet-delivered treatment for social anxiety disorder Cortical activation for adolescent-onset minor depression and major depressive disorder: an fNIRS study Cortical activation for adolescent-onset minor depression and major depressive disorder: an fNIRS study 8-Iso-prostaglandin F2α as a potential biomarker in patients with unipolar and bipolar depression